ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Cost-Effectiveness of Mavacamten for the Treatment of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) in France
Nov 18, 2024, 10:30 AM
«
2931
2932
2933
(current)
2934
2935
2936
2937
2938
2939
2940
»